Literature DB >> 15559999

Optimum parameters in a model for tumour control probability including interpatient heterogeneity.

S Webb1.   

Abstract

A model for computing tumour control probability (TCP) is studied which embodies a dependence on the size of the irradiated volume, the density of clonogenic cells and the dose received, together with the alpha and beta parameters of the linear quadratic model of cell kill. The model can be used to describe situations where both the dose and the clonogenic cell densities are inhomogeneously distributed; however there is still uncertainty about its radiobiological parameters and the author aims to establish parameters for four types of tumour. In its simplest form, when the volumes are spherical, the clonogenic cell density is considered constant throughout the volume and the dose is uniform, the model has been used (by D.J. Brenner, 1993) to predict the radiobiological parameter alpha which allows the model to best fit the observed clinical data for four types of tumour. Here a new set of fits to the data presented by Brenner is constructed using a model which includes the distribution of radiosensitivity across a heterogeneous patient population. It is shown that this leads to a different set of optimum radiobiological parameters when the clonogenic cell density is of the order of 107 cells cm-3.

Entities:  

Mesh:

Year:  1994        PMID: 15559999     DOI: 10.1088/0031-9155/39/11/007

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  9 in total

Review 1.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

2.  Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.

Authors:  Nitin Ohri; Maria Werner-Wasik; Inga S Grills; José Belderbos; Andrew Hope; Di Yan; Larry L Kestin; Matthias Guckenberger; Jan-Jakob Sonke; Jean-Pierre Bissonnette; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-01       Impact factor: 7.038

3.  Is there a selection bias in radiotherapy dose-escalation protocols?

Authors:  Elisabeth Weiss; Viswanathan Ramakrishnan; Paul J Keall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-07       Impact factor: 7.038

4.  Methodology for Registration of Shrinkage Tumors in Head-and-Neck CT Studies.

Authors:  Jianhua Wang; Jianrong Dai; Yongjie Jing; Yanan Huo; Tianye Niu
Journal:  Comput Math Methods Med       Date:  2015-05-18       Impact factor: 2.238

5.  A critical evaluation of the PTW 2D-ARRAY seven29 and OCTAVIUS II phantom for IMRT and VMAT verification.

Authors:  Mohammad Hussein; Elizabeth J Adams; Thomas J Jordan; Catharine H Clark; Andrew Nisbet
Journal:  J Appl Clin Med Phys       Date:  2013-11-04       Impact factor: 2.102

6.  Kinetic modeling of tumor regression incorporating the concept of cancer stem-like cells for patients with locally advanced lung cancer.

Authors:  Hualiang Zhong; Stephen Brown; Suneetha Devpura; X Allen Li; Indrin J Chetty
Journal:  Theor Biol Med Model       Date:  2018-12-27       Impact factor: 2.432

7.  Impact of dose and sensitivity heterogeneity on TCP.

Authors:  Kristin Wiklund; Iuliana Toma-Dasu; Bengt K Lind
Journal:  Comput Math Methods Med       Date:  2014-05-12       Impact factor: 2.238

8.  Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancer.

Authors:  Shu-Wen Wang; Juan Ren; Yan-Li Yan; Chao-Fan Xue; Li Tan; Xiao-Wei Ma
Journal:  Onco Targets Ther       Date:  2016-08-16       Impact factor: 4.147

9.  Quantification of the uncertainties within the radiotherapy dosimetry chain and their impact on tumour control.

Authors:  Matthew Bolt; Catharine H Clark; Andrew Nisbet; Tao Chen
Journal:  Phys Imaging Radiat Oncol       Date:  2021-06-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.